Cargando…
Smartphone application for women with gestational diabetes mellitus: a study protocol for a multicentre randomised controlled trial
INTRODUCTION: The promotion of a healthy diet, physical activity and measurement of blood glucose levels are essential components in the care for women with gestational diabetes mellitus (GDM). Smartphones offer a new way to promote health behaviour. The main aim is to investigate if the use of the...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5372027/ https://www.ncbi.nlm.nih.gov/pubmed/28348183 http://dx.doi.org/10.1136/bmjopen-2016-013117 |
_version_ | 1782518542926610432 |
---|---|
author | Borgen, Iren Garnweidner-Holme, Lisa Maria Jacobsen, Anne Flem Bjerkan, Kirsti Fayyad, Seraj Joranger, Pål Lilleengen, Anne Marie Mosdøl, Annhild Noll, Josef Småstuen, Milada Cvancarova Terragni, Laura Torheim, Liv Elin Lukasse, Mirjam |
author_facet | Borgen, Iren Garnweidner-Holme, Lisa Maria Jacobsen, Anne Flem Bjerkan, Kirsti Fayyad, Seraj Joranger, Pål Lilleengen, Anne Marie Mosdøl, Annhild Noll, Josef Småstuen, Milada Cvancarova Terragni, Laura Torheim, Liv Elin Lukasse, Mirjam |
author_sort | Borgen, Iren |
collection | PubMed |
description | INTRODUCTION: The promotion of a healthy diet, physical activity and measurement of blood glucose levels are essential components in the care for women with gestational diabetes mellitus (GDM). Smartphones offer a new way to promote health behaviour. The main aim is to investigate if the use of the Pregnant+ app, in addition to standard care, results in better blood glucose levels compared with current standard care only, for women with GDM. METHODS AND ANALYSIS: This randomised controlled trial will include 230 pregnant women with GDM followed up at 5 outpatient departments (OPD) in the greater Oslo Region. Women with a 2-hour oral glucose tolerance test (OGTT) ≥9 mmol/L, who own a smartphone, understand Norwegian, Urdu or Somali and are <33 weeks pregnant, are invited. The intervention group receives the Pregnant+ app and standard care. The control group receives standard care only. Block randomisation is performed electronically. Data are collected using self-reported questionnaires and hospital records. Data will be analysed according to the intention-to-treat principle. Groups will be compared using linear regression for the main outcome and χ(2) test for categorical data and Student's t-test or Mann-Whitney-Wilcoxon test for skewed distribution. The main outcome is the glucose level measured at the 2-hour OGTT 3 months postpartum. Secondary outcomes are a change in health behaviour and knowledge about GDM, quality of life, birth weight, mode of delivery and complications for mother and child. ETHICS AND DISSEMINATION: The study is exempt from regional ethics review due to its nature of quality improvement in patient care. Our study has been approved by the Norwegian Social Science Data Services and the patient privacy protections boards governing over the recruitment sites. Findings will be presented in peer-reviewed journals and at conferences. TRIAL REGISTRATION NUMBER: NCT02588729, Post-results. |
format | Online Article Text |
id | pubmed-5372027 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-53720272017-04-12 Smartphone application for women with gestational diabetes mellitus: a study protocol for a multicentre randomised controlled trial Borgen, Iren Garnweidner-Holme, Lisa Maria Jacobsen, Anne Flem Bjerkan, Kirsti Fayyad, Seraj Joranger, Pål Lilleengen, Anne Marie Mosdøl, Annhild Noll, Josef Småstuen, Milada Cvancarova Terragni, Laura Torheim, Liv Elin Lukasse, Mirjam BMJ Open Diabetes and Endocrinology INTRODUCTION: The promotion of a healthy diet, physical activity and measurement of blood glucose levels are essential components in the care for women with gestational diabetes mellitus (GDM). Smartphones offer a new way to promote health behaviour. The main aim is to investigate if the use of the Pregnant+ app, in addition to standard care, results in better blood glucose levels compared with current standard care only, for women with GDM. METHODS AND ANALYSIS: This randomised controlled trial will include 230 pregnant women with GDM followed up at 5 outpatient departments (OPD) in the greater Oslo Region. Women with a 2-hour oral glucose tolerance test (OGTT) ≥9 mmol/L, who own a smartphone, understand Norwegian, Urdu or Somali and are <33 weeks pregnant, are invited. The intervention group receives the Pregnant+ app and standard care. The control group receives standard care only. Block randomisation is performed electronically. Data are collected using self-reported questionnaires and hospital records. Data will be analysed according to the intention-to-treat principle. Groups will be compared using linear regression for the main outcome and χ(2) test for categorical data and Student's t-test or Mann-Whitney-Wilcoxon test for skewed distribution. The main outcome is the glucose level measured at the 2-hour OGTT 3 months postpartum. Secondary outcomes are a change in health behaviour and knowledge about GDM, quality of life, birth weight, mode of delivery and complications for mother and child. ETHICS AND DISSEMINATION: The study is exempt from regional ethics review due to its nature of quality improvement in patient care. Our study has been approved by the Norwegian Social Science Data Services and the patient privacy protections boards governing over the recruitment sites. Findings will be presented in peer-reviewed journals and at conferences. TRIAL REGISTRATION NUMBER: NCT02588729, Post-results. BMJ Publishing Group 2017-03-27 /pmc/articles/PMC5372027/ /pubmed/28348183 http://dx.doi.org/10.1136/bmjopen-2016-013117 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
spellingShingle | Diabetes and Endocrinology Borgen, Iren Garnweidner-Holme, Lisa Maria Jacobsen, Anne Flem Bjerkan, Kirsti Fayyad, Seraj Joranger, Pål Lilleengen, Anne Marie Mosdøl, Annhild Noll, Josef Småstuen, Milada Cvancarova Terragni, Laura Torheim, Liv Elin Lukasse, Mirjam Smartphone application for women with gestational diabetes mellitus: a study protocol for a multicentre randomised controlled trial |
title | Smartphone application for women with gestational diabetes mellitus: a study protocol for a multicentre randomised controlled trial |
title_full | Smartphone application for women with gestational diabetes mellitus: a study protocol for a multicentre randomised controlled trial |
title_fullStr | Smartphone application for women with gestational diabetes mellitus: a study protocol for a multicentre randomised controlled trial |
title_full_unstemmed | Smartphone application for women with gestational diabetes mellitus: a study protocol for a multicentre randomised controlled trial |
title_short | Smartphone application for women with gestational diabetes mellitus: a study protocol for a multicentre randomised controlled trial |
title_sort | smartphone application for women with gestational diabetes mellitus: a study protocol for a multicentre randomised controlled trial |
topic | Diabetes and Endocrinology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5372027/ https://www.ncbi.nlm.nih.gov/pubmed/28348183 http://dx.doi.org/10.1136/bmjopen-2016-013117 |
work_keys_str_mv | AT borgeniren smartphoneapplicationforwomenwithgestationaldiabetesmellitusastudyprotocolforamulticentrerandomisedcontrolledtrial AT garnweidnerholmelisamaria smartphoneapplicationforwomenwithgestationaldiabetesmellitusastudyprotocolforamulticentrerandomisedcontrolledtrial AT jacobsenanneflem smartphoneapplicationforwomenwithgestationaldiabetesmellitusastudyprotocolforamulticentrerandomisedcontrolledtrial AT bjerkankirsti smartphoneapplicationforwomenwithgestationaldiabetesmellitusastudyprotocolforamulticentrerandomisedcontrolledtrial AT fayyadseraj smartphoneapplicationforwomenwithgestationaldiabetesmellitusastudyprotocolforamulticentrerandomisedcontrolledtrial AT jorangerpal smartphoneapplicationforwomenwithgestationaldiabetesmellitusastudyprotocolforamulticentrerandomisedcontrolledtrial AT lilleengenannemarie smartphoneapplicationforwomenwithgestationaldiabetesmellitusastudyprotocolforamulticentrerandomisedcontrolledtrial AT mosdølannhild smartphoneapplicationforwomenwithgestationaldiabetesmellitusastudyprotocolforamulticentrerandomisedcontrolledtrial AT nolljosef smartphoneapplicationforwomenwithgestationaldiabetesmellitusastudyprotocolforamulticentrerandomisedcontrolledtrial AT smastuenmiladacvancarova smartphoneapplicationforwomenwithgestationaldiabetesmellitusastudyprotocolforamulticentrerandomisedcontrolledtrial AT terragnilaura smartphoneapplicationforwomenwithgestationaldiabetesmellitusastudyprotocolforamulticentrerandomisedcontrolledtrial AT torheimlivelin smartphoneapplicationforwomenwithgestationaldiabetesmellitusastudyprotocolforamulticentrerandomisedcontrolledtrial AT lukassemirjam smartphoneapplicationforwomenwithgestationaldiabetesmellitusastudyprotocolforamulticentrerandomisedcontrolledtrial |